Summary of Key Points Core Viewpoint - Shanghai Jianda Zhixin Medical Technology Group Co., Ltd. is providing guarantees for its subsidiaries, with a total guarantee amount expected to reach up to 7 billion RMB, reflecting the company's strategic financial management and support for its subsidiaries' operations [3][4]. Group 1: Guarantee Overview - The company plans to apply for a total credit limit of no more than 15 billion RMB from banks and financial institutions from the 2024 annual general meeting until the 2025 annual general meeting [3]. - The expected total guarantee amount for subsidiaries is capped at 7 billion RMB, with 6.5 billion RMB allocated for subsidiaries with an asset-liability ratio exceeding 70% and 500 million RMB for those below this threshold [3][4]. Group 2: Recent Guarantee Developments - Recently, the company provided joint liability guarantees totaling 780 million RMB for several subsidiaries, including Shanghai Jianda Luyi Technology Co., Ltd. and Beijing Kangle Zhixin Supply Chain Management Co., Ltd. [6][7]. - The guarantee amount for Fujian Del Medical Industry Co., Ltd. is 1.75 billion RMB, which includes a portion allocated for supply chain finance activities [7]. Group 3: Financial Metrics and Risk Management - After the current guarantees, the total utilized guarantee amount is 5.825 billion RMB, representing 393.27% of the company's latest audited net assets attributable to shareholders [15]. - The actual guarantee balance stands at 2.447 billion RMB, which is 165.23% of the company's latest audited net assets [15][16]. - The company has not provided guarantees to entities outside the consolidated financial statements and has no overdue guarantees or litigation-related guarantees [16].
上海建发致新医疗科技集团股份有限公司关于为下属子公司提供担保的进展公告